1.上海中医药大学附属龙华医院奉贤分院呼吸科(上海 201400)
2.上海市浦东新区周浦医院感染科(上海 201318)
3.上海中医药大学附属岳阳中西医结合医院呼吸科(上海 200437)
顾文燕,女,硕士研究生,主治医师,主要从事中西医结合防治呼吸系统疾病临床研究工作
周东花,副主任医师;E-mail:zdhhx@sina.com
扫 描 看 全 文
顾文燕,李晓宁,钟秀君,等.基于“脾主肌肉”理论的慢性阻塞性肺疾病骨骼肌萎缩与细胞凋亡关系及中药干预作用研究进展[J].上海中医药杂志,2023,57(1):100-104.
GU Wenyan,LI Xiaoning,ZHONG Xiujun,et al.Research progress on relationship between skeletal muscle atrophy and apoptosis in COPD based on theory of “spleen dominating muscles” and intervention effect of traditional Chinese medicine[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(1):100-104.
顾文燕,李晓宁,钟秀君,等.基于“脾主肌肉”理论的慢性阻塞性肺疾病骨骼肌萎缩与细胞凋亡关系及中药干预作用研究进展[J].上海中医药杂志,2023,57(1):100-104. DOI: 10.16305/j.1007-1334.2023.2206071.
GU Wenyan,LI Xiaoning,ZHONG Xiujun,et al.Research progress on relationship between skeletal muscle atrophy and apoptosis in COPD based on theory of “spleen dominating muscles” and intervention effect of traditional Chinese medicine[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(1):100-104. DOI: 10.16305/j.1007-1334.2023.2206071.
综述慢性阻塞性肺疾病(COPD)骨骼肌萎缩与细胞凋亡的关系及中药干预作用研究进展。基于“脾主肌肉”理论探讨COPD骨骼肌细胞凋亡可致骨骼肌萎缩,并从单味中药提取物、中药复方、中药制剂方面分别综述具有健脾补肺作用的中药通过调控细胞凋亡干预COPD骨骼肌萎缩的机制。
This paper reviewed the relationship between skeletal muscle atrophy and apoptosis in chronic obstructive pulmonary disease (COPD) and the research progress on traditional Chinese medicine intervention. Based on the theory of “spleen dominating muscles”, it explored that the apoptosis of skeletal muscle cells in COPD could cause skeletal muscle atrophy. And it reviewed the mechanism of traditional Chinese medicine with the function of strengthening the spleen and tonifying the lung to intervene skeletal muscle atrophy in COPD by regulating cell apoptosis, from the aspects of traditional Chinese medicine extract, traditional Chinese medicine compound and traditional Chinese medicine preparation.
慢性阻塞性肺疾病骨骼肌萎缩细胞凋亡中药脾主肌肉研究进展
chronic obstructive pulmonary diseaseskeletal muscle atrophycell apoptosistraditional Chinese medicinespleen dominating musclesresearch progress
LOZANO R, NAGHAVI M, FOREMAN K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010[J]. Lancet, 2012, 380(9859): 2095-2128.
KLIMATHIANAKI M, VAPORIDI K, GEORGOPOULOS D. Respiratory muscle dysfunction in COPD: from muscles to cell[J]. Curr Drug Targets, 2011, 12(4): 478-488.
OTTENHEIJM C A, HEUNKS L M, DEKHUIJZEN P N. Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept[J]. Am J Respir Crit Care Med, 2007, 175(12): 1233-1240.
REMELS A H, GOSKER H R, VELDEN J, et al. Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity[J]. Clin Chest Med, 2007, 28(3): 537-552.
HALESTRAP A P, MCSTAY G O, CLARKE S J. The permeability transition pore complex: another view[J]. Biochimie, 2002, 84(23): 153-166.
BERGMANN T J, MOLINARI M. Three branches to rule them all UPR signaling in response to chemically-versus misfolded proteins-induced ER stress[J]. Biol Cell, 2018, 110(9): 197-204.
NAKAGAWA T, ZHU H, MORISHIMA N, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta[J]. Nature, 2000, 403(6765): 98-103.
ROE N D, REN J. Oxidative activation of Ca2+/calmodulin-activated kinaseⅡmediates ER stress-induced cardiac dysfunction and apoptosis[J]. Am J Physiol Heart Circ Physiol, 2013, 304(6): H828-H839.
ABDULGHANI J, EL-DEIRY W S. TRAIL receptor signaling and therapeutics[J]. Expetr Opin Ther Targets, 2010, 14(10): 1091-1108.
CHAMI M, PRANDINI A, CAMPAELLA M, et al. Bcl-2 and Bax exert opposing effects on Ca2+ signaling, which do not depend on their putative pore-forming region[J]. Biol Chem, 2004, 297(52): 54581-54589.
HITOMI J, KATAYAMA T, TANIGUCHI M, et al. Apoptosis induced by endoplasmic reticulum stress depends on activation of caspase-3 via caspase-12[J]. Neurosci Lett, 2004, 357(2): 127-130.
NEEKHRA A, LUTHRA S, CHWA M, et al. Caspase-8, -12, and -3 activation by 7-ketocholesterol in retinal neurosensory cells[J]. Invest Ophthalmol Vis Sci, 2007, 48(3): 1362-1367.
周兰英,孙圣华,李定梅,等. Bcl-2及Bax表达与COPD大鼠骨骼肌细胞凋亡的相关性[J]. 医学研究杂志,2011, 40(8): 104-108.
SCATENA R, BOTTONI P, BOTTA G, et al. The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic[J]. Am J Physiol Cell Physiol, 2007, 293(1): 12-21.
王富霞. Caspase-12和m-Calpain蛋白及mRNA在COPD模型大鼠膈肌和趾长伸肌中表达的研究[D]. 郑州:郑州大学,2014.
李庆伟,王磊,张国俊. 钙蛋白酶在慢性阻塞性肺疾病模型大鼠膈肌和趾长伸肌中的表达[J]. 中华结核和呼吸杂志,2014, 37(5): 377-379.
郭丽青. 六味补气胶囊对COPD模型大鼠膈肌疲劳的干预作用及PERK信号通路的影响[D]. 合肥:安徽中医药大学,2018.
毛静,李亚,李素云,等. 补肺健脾方调控TNF-α/TNFR/NF-κB通路对COPD大鼠骨骼肌炎性反应的影响[J]. 中华中医药杂志,2018, 33(5): 1863-1867.
李亚,毛静,董玉琼,等. 补肺健脾方对慢性阻塞性肺疾病大鼠骨骼肌Fas/FasL/Caspase-3的影响[J]. 中华中医药杂志,2017, 32(3): 1238-1241.
何馨,吴艳军,于刚刚,等. 慢性阻塞性肺疾病小鼠膈肌细胞凋亡的机制研究[J]. 临床和实验医学杂志,2018, 17(22): 2356-2360.
鲁瑛. 中医四部经典[M]. 太原:山西科学技术出版社,2008: 18-55.
唐容川. 唐容川医学全书[M]. 北京:中国中医药出版社,1999: 11.
孙玉信. 对脾主肌肉的认识及临床应用体会[J]. 中国中医基础医学杂志,2018, 24(5): 710-712.
尹光耀,张武宁,何雪芬,等. 脾虚证胃黏膜组织细胞病理学研究[J]. 中国中西医结合杂志,1999, 19(11): 660-663.
刘友章,刘江凯,弓淑珍,等. 中医“脾主肌肉”与骨骼肌舒缩运动中能量代谢关系的探讨[J]. 江苏中医药,2009, 41(4): 5-7.
宋雅芳,王晓燕,刘友章,等. 健脾益气中药对脾虚大鼠骨骼肌、胃黏膜线粒体超微结构的影像[J]. 中药药理与临床,2009, 25(2): 6-8.
WANG L, GU W, SHI Y, et al. Protective effects of astragaloside Ⅳ on IL-8-treated diaphragmatic muscle cells[J]. Exp Ther Med, 2019, 17(1): 519-524.
WANG L, TAN Y, GAO L, et al. Effect of astragaloside on diaphragm cell apoptosis in chronic obstructive pulmonary disease[J]. Food Sci Nutr, 2020, 8(12): 6357-6366.
楚琪,李昭,汲坤,等. 黄芪甲苷对阻塞性肺疾病大鼠caspase-12表达影响[J]. 中国公共卫生,2015, 31(11): 1406-1409.
MEIQIAN Z, LEYING Z, CHANG C. Asragaloside Ⅳ inhibits cigarette smoke-induced pulmonary inflammation in mice[J]. Inflammation, 2018, 41(5): 1671-1680.
毛静,李亚,李素云,等. 补肺健脾方调控TNF-α/TNFR/NF-κB通路对COPD大鼠骨骼肌炎性反应的影响[J]. 中华中医药杂志,2018, 33(5): 1863-1867.
毛静,王丽丽,李亚,等. 补肺健脾方对COPD大鼠骨骼肌TNF-α、caspase-8及caspase-3的影响[J]. 中华中医药杂志,2018, 33(6): 2373-2377.
毛静,王丽丽,李亚,等. 补肺健脾方对COPD大鼠骨骼肌Fas、FasL、Bcl-2及Bax表达的影响[J]. 中华中医药杂志,2017, 32(2): 746-749.
毛静,李亚,董玉琼,等. 补肺健脾方调控Akt信号通路对COPD大鼠骨骼肌细胞凋亡的影响[J]. 中华中医药杂志,2017, 32(8): 3514-3519.
于旭华,胡涛,毛峪泉,等. 健脾益肺Ⅱ号减少香烟暴露联合脂多糖气道滴注诱导的肺组织凋亡的机制研究[J]. 中药药理与临床,2019, 35(4): 165-169.
于旭华,胡涛,陈远彬,等. 健脾益肺Ⅱ号方对烟草烟雾暴露联合脂多糖气道滴注诱导大鼠膈肌损伤的影响[J]. 中国中西医结合杂志,2020, 40(7): 829-835.
林琳,吴蕾,许银姬,等. 健脾益肺Ⅱ号对COPD模型大鼠炎症的抑制及缓解膈肌疲劳作用的研究[C]//中华中医药学会. 第十七次全国中医肺系病学术交流会论文集. 北京:中华中医药学会,2013: 167-171.
宋璟. 培土生金法对COPD大鼠膈肌细胞增殖与凋亡的影响及临床应用[D]. 广州:广州中医药大学,2016.
范方馨. 脾虚模型大鼠肌肉损伤的分子机制及补中益气汤的干预作用[D]. 北京:北京中医药大学,2020.
张倩,吕晓东,庞立健,等. 基于网络药理学和生物信息学探讨补中益气汤治疗慢性阻塞性肺疾病作用机制[J]. 辽宁中医药大学学报,2021, 23(12): 120-125,17.
吴玲玲,郭红云. 参麦注射液联合针刺干预COPD合并呼吸衰竭机械通气撤机困难的疗效及对膈肌功能、NT-proBNP和HS-CRP的影响[J]. 现代中西医结合杂志, 2019, 28(29): 3233-3238,3268.
蒋东霞,赵丽敏,马利军. 参麦注射液对慢性缺氧大鼠膈肌细胞凋亡的影响[J]. 医药导报,2009, 28(2): 150-152.
赵丽敏,熊盛道,牛汝楫,等. 参麦注射液和氨茶碱对慢性缺氧大鼠膈肌细胞凋亡及相关基因表达的影响[J]. 中华结核和呼吸杂志,2003, 26(10): 33-36.
朱少华,韩建新,王少锋. 定喘胶囊对脾虚COPD模型大鼠骨骼肌细胞BCl-2及Bax的影响[J]. 光明中医,2012, 27(8): 1531-1532.
0
浏览量
268
下载量
0
CSCD
1
CNKI被引量
关联资源
相关文章
相关作者
相关机构